サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/04/06 | 1,862 | 1,881 | 1,812 | 1,812 | -67 | -3.6% | 268,600 |
2021/04/05 | 1,912 | 1,920 | 1,860 | 1,879 | -27 | -1.4% | 238,700 |
2021/04/02 | 1,936 | 1,965 | 1,873 | 1,906 | -20 | -1% | 411,800 |
2021/04/01 | 1,928 | 1,955 | 1,910 | 1,926 | +11 | +0.6% | 285,000 |
2021/03/31 | 1,910 | 1,931 | 1,881 | 1,915 | +5 | +0.3% | 270,500 |
2021/03/30 | 1,838 | 1,917 | 1,828 | 1,910 | +64 | +3.5% | 437,900 |
2021/03/29 | 1,939 | 1,940 | 1,824 | 1,846 | -36 | -1.9% | 329,500 |
2021/03/26 | 1,898 | 1,922 | 1,856 | 1,882 | +24 | +1.3% | 253,500 |
2021/03/25 | 1,860 | 1,909 | 1,778 | 1,858 | -27 | -1.4% | 534,000 |
2021/03/24 | 1,938 | 1,940 | 1,857 | 1,885 | -74 | -3.8% | 585,900 |
2021/03/23 | 1,883 | 2,047 | 1,883 | 1,959 | +78 | +4.1% | 1,563,200 |
2021/03/22 | 1,750 | 1,899 | 1,742 | 1,881 | +107 | +6% | 920,400 |
2021/03/19 | 1,731 | 1,801 | 1,691 | 1,774 | +83 | +4.9% | 928,000 |
2021/03/18 | 1,540 | 1,714 | 1,530 | 1,691 | +124 | +7.9% | 902,700 |
2021/03/17 | 1,530 | 1,576 | 1,515 | 1,567 | +24 | +1.6% | 314,000 |
2021/03/16 | 1,533 | 1,554 | 1,524 | 1,543 | +12 | +0.8% | 207,400 |
2021/03/15 | 1,515 | 1,542 | 1,502 | 1,531 | -11 | -0.7% | 212,400 |
2021/03/12 | 1,487 | 1,549 | 1,481 | 1,542 | +72 | +4.9% | 379,800 |
2021/03/11 | 1,483 | 1,485 | 1,436 | 1,470 | -6 | -0.4% | 314,100 |
2021/03/10 | 1,481 | 1,498 | 1,460 | 1,476 | +6 | +0.4% | 266,600 |
2021/03/09 | 1,434 | 1,482 | 1,396 | 1,470 | +32 | +2.2% | 393,800 |
2021/03/08 | 1,500 | 1,500 | 1,432 | 1,438 | -59 | -3.9% | 447,500 |
2021/03/05 | 1,480 | 1,511 | 1,450 | 1,497 | -3 | -0.2% | 387,800 |
2021/03/04 | 1,520 | 1,522 | 1,480 | 1,500 | -50 | -3.2% | 431,300 |
2021/03/03 | 1,655 | 1,660 | 1,533 | 1,550 | -112 | -6.7% | 649,000 |
2021/03/02 | 1,704 | 1,722 | 1,653 | 1,662 | -76 | -4.4% | 392,900 |
2021/03/01 | 1,712 | 1,800 | 1,659 | 1,738 | +37 | +2.2% | 646,700 |
2021/02/26 | 1,706 | 1,768 | 1,690 | 1,701 | -43 | -2.5% | 315,100 |
2021/02/25 | 1,702 | 1,757 | 1,702 | 1,744 | +50 | +3% | 208,200 |
2021/02/24 | 1,736 | 1,757 | 1,686 | 1,694 | -57 | -3.3% | 277,300 |
2021/02/22 | 1,718 | 1,767 | 1,718 | 1,751 | +41 | +2.4% | 234,900 |
2021/02/19 | 1,782 | 1,793 | 1,682 | 1,710 | -90 | -5% | 383,600 |
2021/02/18 | 1,781 | 1,819 | 1,768 | 1,800 | +22 | +1.2% | 363,300 |
2021/02/17 | 1,704 | 1,784 | 1,700 | 1,778 | +70 | +4.1% | 391,500 |
2021/02/16 | 1,727 | 1,746 | 1,703 | 1,708 | -19 | -1.1% | 184,500 |
2021/02/15 | 1,750 | 1,752 | 1,711 | 1,727 | -26 | -1.5% | 207,300 |
2021/02/12 | 1,730 | 1,757 | 1,708 | 1,753 | +21 | +1.2% | 199,400 |
2021/02/10 | 1,660 | 1,733 | 1,657 | 1,732 | +61 | +3.7% | 228,500 |
2021/02/09 | 1,717 | 1,718 | 1,667 | 1,671 | -49 | -2.8% | 323,000 |
2021/02/08 | 1,741 | 1,774 | 1,717 | 1,720 | -29 | -1.7% | 250,800 |
2021/02/05 | 1,731 | 1,768 | 1,723 | 1,749 | +24 | +1.4% | 259,200 |
2021/02/04 | 1,728 | 1,737 | 1,702 | 1,725 | -13 | -0.7% | 201,900 |
2021/02/03 | 1,750 | 1,808 | 1,715 | 1,738 | -28 | -1.6% | 415,100 |
2021/02/02 | 1,694 | 1,776 | 1,691 | 1,766 | +65 | +3.8% | 516,800 |
2021/02/01 | 1,605 | 1,713 | 1,590 | 1,701 | +64 | +3.9% | 333,800 |
2021/01/29 | 1,690 | 1,730 | 1,625 | 1,637 | -55 | -3.3% | 445,000 |
2021/01/28 | 1,675 | 1,716 | 1,673 | 1,692 | -39 | -2.3% | 295,100 |
2021/01/27 | 1,690 | 1,733 | 1,690 | 1,731 | +51 | +3% | 227,400 |
2021/01/26 | 1,736 | 1,745 | 1,672 | 1,680 | -65 | -3.7% | 276,400 |
2021/01/25 | 1,747 | 1,756 | 1,717 | 1,745 | +5 | +0.3% | 256,200 |
1001~
1050
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム